Nabriva Therapeutics plc Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2022-04-22: Study NCT05111002; Company role Collaborator; Phase Phase 1, Phase 2; Status Terminated.
- 2022-03-01: Study NCT05225805; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2018-05-24: Study NCT03709914; Company role Lead sponsor; Phase Phase 1; Status Unknown.
- 2018-01-11: Study NCT03709927; Company role Lead sponsor; Phase Phase 1; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2022-04-22 | NCT05111002 Lefamulin for M. Genitalium Treatment Failures | Collaborator Lead: University of Washington | Phase 1, Phase 2 | Terminated Results posted | Mycoplasma Genitalium Infection | 12 | 2023-11-30 |
| 2022-03-01 | NCT05225805 Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis | Lead sponsor | Phase 1 | Completed Results posted | Cystic Fibrosis | 13 | 2023-01-13 |
| 2018-05-24 | NCT03709914 PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age) | Lead sponsor | Phase 1 | Unknown | Pediatric ALL | 21 | 2026-01-10 |
| 2018-01-11 | NCT03709927 4-way Crossover QT Evaluation in Healthy Subjects | Lead sponsor | Phase 1 | Completed | Cardiac Repolarization in Healthy Subjects | 41 | 2018-08-21 |
| 2017-01-08 | NCT03131141 A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781 | Lead sponsor | Phase 1 | Completed | Healthy | 10 | 2018-03-30 |
| 2016-08 | NCT02813694 Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia | Lead sponsor | Phase 3 | Completed Results posted | Community Acquired Pneumonia | 738 | 2018-01 |
| 2016-04 | NCT02753946 Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections | Lead sponsor | Phase 2, Phase 3 | Completed Results posted | Urinary Tract Infection Symptomatic; Acute Pyelonephritis; Urinary Tract Infection Complicated | 465 | 2017-05-30 |
| 2015-09 | NCT02559310 Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia | Lead sponsor | Phase 3 | Completed Results posted | Community Acquired Pneumonia | 551 | 2017-05 |
| 2015-06 | NCT02557789 Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects | Lead sponsor | Phase 1 | Completed | Healthy | 20 | 2015-06 |
| 2010-05 | NCT01119105 Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) | Lead sponsor | Phase 2 | Completed Results posted | Bacterial Infections; Infection | 210 | 2011-02-03 |